Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
GROW-School for Oncology and Developmental Biology, Department of Epidemiology, Maastricht University Medical Centre, Maastricht, the Netherlands.
JAMA Neurol. 2022 Sep 1;79(9):888-900. doi: 10.1001/jamaneurol.2022.2189.
To date, no systematic review has taken a meta-analytic approach to estimating the prevalence and incidence of tinnitus in the general population.
To provide frequency estimates of tinnitus worldwide.
An umbrella review followed by a traditional systematic review was performed by searching PubMed-MEDLINE and Embase from inception through November 19, 2021.
Research data from the general population were selected, and studies based on patients or on subgroups of the population with selected lifestyle habits were excluded. No restrictions were applied according to date, age, sex, and country.
Relevant extracted information included type of study, time and location, end point, population characteristics, and tinnitus definition. The study followed the Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guideline.
Pooled prevalence estimates of any tinnitus, severe tinnitus, chronic tinnitus, and diagnosed tinnitus as well as incidence of tinnitus were obtained using random-effects meta-analytic models; heterogeneity between studies was controlled using the χ2 test, and inconsistency was measured using the I2 statistic.
Among 767 publications, 113 eligible articles published between 1972 and 2021 were identified, and prevalence estimates from 83 articles and incidence estimates from 12 articles were extracted. The pooled prevalence of any tinnitus among adults was 14.4% (95% CI, 12.6%-16.5%) and ranged from 4.1% (95% CI, 3.7%-4.4%) to 37.2% (95% CI, 34.6%-39.9%). Prevalence estimates did not significantly differ by sex (14.1% [95% CI, 11.6%-17.0%] among male individuals; 13.1% [95% CI, 10.5%-16.2%] among female individuals), but increased prevalence was associated with age (9.7% [95% CI, 7.4%-12.5%] among adults aged 18-44 years; 13.7% [95% CI, 11.0%-17.0%] among those aged 45-64 years; and 23.6% [95% CI, 19.4%-28.5%] among those aged ≥65 years; P < .001 among age groups). The pooled prevalence of severe tinnitus was 2.3% (95% CI, 1.7%-3.1%), ranging from 0.5% (95% CI, 0.3%-0.7%) to 12.6% (95% CI, 11.1%-14.1%). The pooled prevalence of chronic tinnitus was 9.8% (95% CI, 4.7%-19.3%) and the pooled prevalence of diagnosed tinnitus was 3.4% (95% CI, 2.1%-5.5%). The pooled incidence rate of any tinnitus was 1164 per 100 000 person-years (95% CI, 479-2828 per 100 000 person-years).
Despite the substantial heterogeneity among studies, this comprehensive systematic review on the prevalence and incidence of tinnitus suggests that tinnitus affects more than 740 million adults globally and is perceived as a major problem by more than 120 million people, mostly aged 65 years or older. Health policy makers should consider the global burden of tinnitus, and greater effort should be devoted to boost research on tinnitus.
迄今为止,尚无系统评价采用荟萃分析方法来估计普通人群中耳鸣的患病率和发病率。
提供全球耳鸣的频率估计值。
通过检索 PubMed-MEDLINE 和 Embase,从成立到 2021 年 11 月 19 日进行了伞式综述和传统系统综述。
选择了来自普通人群的研究数据,并排除了基于患者或具有特定生活方式习惯的人群的研究。根据日期、年龄、性别和国家没有任何限制。
相关提取信息包括研究类型、时间和地点、终点、人口特征和耳鸣定义。该研究遵循观察性研究荟萃分析(MOOSE)报告指南。
使用随机效应荟萃分析模型获得任何耳鸣、严重耳鸣、慢性耳鸣和诊断性耳鸣的汇总患病率估计值;使用 χ2 检验控制研究间的异质性,并使用 I2 统计测量不一致性。
在 767 篇出版物中,确定了 113 篇发表于 1972 年至 2021 年的合格文章,并从 83 篇文章中提取了患病率估计值和 12 篇文章的发病率估计值。成年人中任何耳鸣的汇总患病率为 14.4%(95%CI,12.6%-16.5%),范围从 4.1%(95%CI,3.7%-4.4%)到 37.2%(95%CI,34.6%-39.9%)。性别间的患病率估计值无显著差异(14.1%[95%CI,11.6%-17.0%]在男性个体中;13.1%[95%CI,10.5%-16.2%]在女性个体中),但随着年龄的增长,患病率增加(18-44 岁的成年人中为 9.7%[95%CI,7.4%-12.5%];45-64 岁的成年人中为 13.7%[95%CI,11.0%-17.0%];65 岁及以上的成年人中为 23.6%[95%CI,19.4%-28.5%];组间差异有统计学意义,P<0.001)。严重耳鸣的汇总患病率为 2.3%(95%CI,1.7%-3.1%),范围从 0.5%(95%CI,0.3%-0.7%)到 12.6%(95%CI,11.1%-14.1%)。慢性耳鸣的汇总患病率为 9.8%(95%CI,4.7%-19.3%),诊断性耳鸣的汇总患病率为 3.4%(95%CI,2.1%-5.5%)。任何耳鸣的汇总发病率为 1164/100000 人年(95%CI,479-2828/100000 人年)。
尽管研究间存在很大的异质性,但这项关于耳鸣患病率和发病率的综合系统评价表明,耳鸣影响了全球超过 7.4 亿成年人,超过 1.2 亿人认为耳鸣是一个主要问题,其中大多数人年龄在 65 岁或以上。卫生政策制定者应考虑耳鸣的全球负担,并加大努力提高耳鸣研究水平。